glp-1 chicago Can Microdose Agonists Help Autoimmune Disease? Using GLP-1 Agonists with Biologics

When the body loses weight, it normally reduces energy expenditure as a compensatory survival mechanism

However, these variants did not affect the DNA repair activity of APE1, and they do not contribute to the risk of developing sALS (Hayward et al., 1999

We tend to be more prone to post-inflammatory pigmentation, so any energy-based treatment needs to be dosed carefully to avoid triggering dark patches

So were going to need a combination of different kinds of evidence

They are not regulated by the FDA for human consumption, which means there is no oversight on purity, potency, contamination, or dosing accuracy

Fasano A 1